(Q37875253)

24 August 2017

1 reference

title

IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature (English)

1 reference

24 August 2017

0 references

Kunzang Chosdol

7

0 references

author name string

Prerana Jha

1

1 reference

24 August 2017

Vaishali Suri

2

1 reference

24 August 2017

Vikas Sharma

3

1 reference

24 August 2017

Geetika Singh

4

1 reference

24 August 2017

Mehar Chand Sharma

5

1 reference

24 August 2017

Pankaj Pathak

6

1 reference

24 August 2017

Pankaj Jha

8

1 reference

24 August 2017

Ashish Suri

9

1 reference

24 August 2017

Ashok Kumar Mahapatra

10

1 reference

24 August 2017

Shashank Sharad Kale

11

1 reference

24 August 2017

Chitra Sarkar

12

1 reference

24 August 2017

publication date

3 May 2011

1 reference

Experimental and Molecular Pathology

24 August 2017

published in

1 reference

24 August 2017

volume

91

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

385-393

1 reference

Analysis of the IDH1 codon 132 mutation in brain tumors

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Segregation of non-p.R132H mutations in IDH1 in distinct molecular subtypes of glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Detection of IDH1 and IDH2 mutations by fluorescence melting curve analysis as a diagnostic tool for brain biopsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Expanding chemical biology of 2-oxoglutarate oxygenases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Recurring mutations found by sequencing an acute myeloid leukemia genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

PCR- and restriction endonuclease-based detection of IDH1 mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Genetic pathways to glioblastoma: a population-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

An integrated genomic analysis of human glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Analysis of IDH1 and IDH2 mutations in Japanese glioma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

IDH1 and IDH2 mutations in gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2011.04.017

10.1016/J.YEXMP.2011.04.017

7 January 2021

Identifiers

DOI

1 reference

24 August 2017

1 reference